NCT04646876View on ClinicalTrials.gov

Mgso4 as Neuroprotective in Post Traumatic Brain Injury

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

March 12, 2020

Study Completion Date

June 2, 2020

Conditions
Magnesium SulphateTraumatic Brain InjuryBrainInjury
Interventions
DRUG

Magnesium Sulfate

Prospective , comparative , double blind study

DRUG

Placebo

Prospective , comparative , double blind study

Trial Locations (1)

11511

Faculty of medicine , Cairo university, Cairo

All Listed Sponsors
lead

Osama Mohamed Abdelwahab

OTHER

NCT04646876 - Mgso4 as Neuroprotective in Post Traumatic Brain Injury | Biotech Hunter | Biotech Hunter